Aon plc AON
Composite 58/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 42/100 — a slight mark against it.
Quality ranks 74/100 — a moderate point in its favour. Growth ranks 67/100 — a moderate point in its favour. Balance-sheet strength ranks 60/100 — a slight point in its favour.
Momentum ranks 42/100 — a slight mark against it. Valuation ranks 42/100 — a slight mark against it. Income ranks 44/100 — a slight mark against it.
What the company does Aon plc is a global professional services firm offering risk, health, wealth, and reinsurance solutions across 150+ countries. Its segments include commercial risk brokerage, global risk consulting, health benefits consulting, and retirement consulting. The firm also provides capital raising, M&A advisory, and pension risk transfer services.
Key financials Aon reports strong profitability metrics: ROE 44.7%, ROA 5.8%, and ROCE 22.3%. Margins are robust with gross 48.2%, operating 23.5%, and net 22.3%. Revenue grew 9.4% while EPS surged 33.3%. Leverage is moderate with Debt/Equity at 1.63 and Net debt/EBITDA at 2.50.
Stock health Momentum is weak with 3m +0.58%, 6m -4.35%, and 12m -11.47%. RSI(14) stands at 31.50, indicating oversold conditions. Piotroski F-Score is 7/9, suggesting solid financial health. Dividend yield is 1.0% with a conservative payout ratio of 17.2%.
Price vs fair value The stock trades at a discount of 25.70% versus the analyst mean target of 404.05. - Aon fell 6.6% after freezing buybacks to fund a $17B USI acquisition (2026-09-01). - Shares dropped 10% on news of the $17B USI deal (2026-08-31). - Sector headwinds weighed on financial stocks amid the announcement (2026-08-31).
Looking forward Forward P/E is 18.38 and EV/EBITDA is 15.30, aligning with a fair-value assessment. Growth and quality scores (68.9 and 73.8) remain strong, offsetting valuation and momentum headwinds. Execution of the USI integration will be a key near-term catalyst.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.